帕博利珠单抗继发大疱性类天疱疮，酷似中毒性表皮坏死松解症。 - Suppr

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis.

作者信息

Qiu Connie, Shevchenko Alina, Hsu Sylvia

机构信息

Department of Dermatology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

出版信息

JAAD Case Rep. 2020 Apr 29;6(5):400-402. doi: 10.1016/j.jdcr.2020.03.003. eCollection 2020 May.

DOI:10.1016/j.jdcr.2020.03.003

PMID:32382629

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7200194/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d840/7200194/6aa20b9a0862/gr1.jpg

相似文献

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis.

JAAD Case Rep. 2020 Apr 29;6(5):400-402. doi: 10.1016/j.jdcr.2020.03.003. eCollection 2020 May.

Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.

Cureus. 2022 Oct 14;14(10):e30309. doi: 10.7759/cureus.30309. eCollection 2022 Oct.

Paraneoplastic pemphigus mimicking toxic epidermal necrolysis: An underdiagnosed entity?

JAAD Case Rep. 2017 Dec 19;4(1):67-71. doi: 10.1016/j.jdcr.2017.11.002. eCollection 2018 Jan.

Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma.

JAAD Case Rep. 2018 Oct 10;4(9):930-933. doi: 10.1016/j.jdcr.2018.08.003. eCollection 2018 Oct.

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature.

Melanoma Res. 2018 Dec;28(6):491-501. doi: 10.1097/CMR.0000000000000500.

[Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].

Med Sante Trop. 2014 Jan-Mar;24(1):94-8. doi: 10.1684/mst.2013.0272.

Multifocal bullous fixed drug eruption mimicking Stevens-Johnson syndrome.

Indian J Dermatol Venereol Leprol. 2002 May-Jun;68(3):175-6.

Bullous pemphigoid secondary to saxagliptin mimicking toxic epidermal necrolysis.

Australas J Dermatol. 2022 Feb;63(1):139-140. doi: 10.1111/ajd.13775. Epub 2021 Dec 28.

Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: A case series.

Pediatr Dermatol. 2018 May;35(3):392-396. doi: 10.1111/pde.13450. Epub 2018 Mar 24.

Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Br J Dermatol. 2013 Apr;168(4):726-32. doi: 10.1111/bjd.12133. Epub 2013 Feb 16.

引用本文的文献

Immune Checkpoint Inhibitors as Independent and Synergistic Drivers of SJS/TEN: A FAERS-Based Analysis.

medRxiv. 2025 Jun 30:2025.06.21.25330030. doi: 10.1101/2025.06.21.25330030.

Steroid resistant bullous pemphigoid induced by pembrolizumab in a patient with metastatic lung adenocarcinoma: case report and review of the literature.

Discov Oncol. 2025 Jul 1;16(1):1195. doi: 10.1007/s12672-025-02377-7.

An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and Pneumonitis.

J Med Cases. 2025 Feb;16(2):69-76. doi: 10.14740/jmc5089. Epub 2025 Feb 2.

Bullous pemphigoid mimicking toxic epidermal necrolysis.

An Bras Dermatol. 2025 Jan-Feb;100(1):178-180. doi: 10.1016/j.abd.2024.03.009. Epub 2024 Nov 8.

Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.

J Dermatol. 2024 Jan;51(1):3-11. doi: 10.1111/1346-8138.17039. Epub 2023 Nov 30.

Bullous Pemphigoid in a Centenarian Male Simulating Toxic Epidermal Necrolysis.

Cureus. 2023 Sep 11;15(9):e45037. doi: 10.7759/cureus.45037. eCollection 2023 Sep.

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid.

Front Oncol. 2023 Mar 3;13:1095694. doi: 10.3389/fonc.2023.1095694. eCollection 2023.

Skin Manifestation Induced by Immune Checkpoint Inhibitors.

Clin Cosmet Investig Dermatol. 2022 May 10;15:829-841. doi: 10.2147/CCID.S364243. eCollection 2022.

An Unusual TEN-Like Presentation of Juvenile Bullous Pemphigoid: A Diagnostic Challenge.

Case Rep Dermatol Med. 2022 Apr 11;2022:8507156. doi: 10.1155/2022/8507156. eCollection 2022.

Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.

Clin Cosmet Investig Dermatol. 2022 Apr 14;15:661-673. doi: 10.2147/CCID.S267573. eCollection 2022.

本文引用的文献

Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Metastatic Cervical Squamous Cell Carcinoma: A Case Report.

Am J Dermatopathol. 2020 Apr;42(4):292-296. doi: 10.1097/DAD.0000000000001527.

Hydrochlorothiazide vs Venlafaxine: Drug-induced Bullous Pemphigoid.

Cureus. 2019 Jun 25;11(6):e4999. doi: 10.7759/cureus.4999.

Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.

J Autoimmun. 2019 Nov;104:102310. doi: 10.1016/j.jaut.2019.102310. Epub 2019 Aug 15.

Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events.

J Am Acad Dermatol. 2020 Feb;82(2):311-316. doi: 10.1016/j.jaad.2019.06.035. Epub 2019 Jun 21.

Pembrolizumab-induced bullous pemphigoid.

JAAD Case Rep. 2019 Apr 5;5(4):362-364. doi: 10.1016/j.jdcr.2019.02.008. eCollection 2019 Apr.

Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.

Front Immunol. 2018 Mar 13;9:479. doi: 10.3389/fimmu.2018.00479. eCollection 2018.

A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors.

Int J Dermatol. 2018 Jun;57(6):664-669. doi: 10.1111/ijd.13984. Epub 2018 Apr 6.

Skin biopsy: Biopsy issues in specific diseases.

J Am Acad Dermatol. 2016 Jan;74(1):1-16; quiz 17-8. doi: 10.1016/j.jaad.2015.06.033.

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.

Lancet. 2014 Sep 20;384(9948):1109-17. doi: 10.1016/S0140-6736(14)60958-2. Epub 2014 Jul 15.

Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.

J Am Acad Dermatol. 2013 Nov;69(5):748-753. doi: 10.1016/j.jaad.2013.07.009. Epub 2013 Aug 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献